Pulmonary circulation
The pulmonary circulation pushes the whole cardiac output through the lungs at roughly a sixth of systemic arterial pressure and about a tenth of systemic vascular resistance, so blood can pick up oxygen without flooding the alveoli.
What it normally does
The right ventricle moves the same cardiac output as the left - about 5 L/min at rest - but against a mean pulmonary artery pressure of only about 14 mmHg (normal is roughly 14 plus or minus 3, and 20 mmHg or less is taken as the upper limit of normal). Its free wall is only a few millimetres thick and crescentic in cross-section: it is built to eject volume at low pressure, not to generate pressure. An unprepared right ventricle can acutely raise mean pulmonary artery pressure to only about 40 mmHg (systolic of the order of 50 to 60) before it dilates and fails; a ventricle hypertrophied over months can generate considerably more.
a sudden rise in afterload - a large pulmonary embolus - overwhelms it within hours, while the same pressure arrived at slowly is tolerated for years. It also explains the paradox that a systolic pressure above about 60 mmHg on echocardiography argues against a purely acute cause: the right ventricle could not have got there overnight.
The bed is enormously compliant and much of it is unrecruited at rest, particularly at the lung apices where alveolar pressure can exceed capillary pressure. On exercise, closed capillaries open and open ones widen (recruitment and distension), so pulmonary vascular resistance - normally of the order of 1 Wood unit, against about 15 for the systemic circulation - falls further, and flow can rise threefold or more for only a small rise in pressure.
a large fraction of the bed (conventionally more than half) can be obstructed or destroyed before resting pressure climbs and symptoms appear, which is why both pulmonary embolism and pulmonary hypertension present late. Conversely, when that reserve is lost the pressure-flow relationship becomes steep and exercise produces a large pressure jump instead of a fall in resistance.
Pulmonary arterioles do the opposite of systemic ones: a fall in ALVEOLAR oxygen tension (not arterial) makes them constrict. Hypoxic pulmonary vasoconstriction begins as alveolar PO2 falls below roughly 70 mmHg and becomes marked below about 60; the sensor is in the smooth muscle itself, where hypoxia inhibits voltage-gated potassium channels, depolarising the cell and opening L-type calcium channels. Blood is pushed away from poorly ventilated alveoli toward well-ventilated ones.
when the stimulus is patchy it matches perfusion to ventilation and protects arterial oxygenation - but when the whole lung is hypoxic the entire bed constricts at once and the pressure rises. It is also why raising alveolar oxygen lowers pulmonary artery pressure, and why any drug that dilates pulmonary vessels indiscriminately can worsen shunt and drop the arterial oxygen.
The bed sits in series with essentially the whole venous return, so it acts as the body's filter: material travelling in systemic venous blood - thrombus from a deep leg or pelvic vein, air, fat, amniotic fluid, injected particulate - is delivered to a pulmonary artery. Two qualifications matter. The bronchial and thebesian veins are the exception to the series arrangement, draining oxygenated-then-deoxygenated blood into the pulmonary veins and left heart (the normal anatomical shunt, a couple of per cent of output, and the reason a normal PaO2 is below alveolar PO2). And a right-to-left shunt such as a patent foramen ovale lets venous material bypass the filter entirely.
leg vein thrombosis presents as a lung problem, and the same anatomy explains paradoxical embolism - a venous clot causing a stroke - in a patient with a patent foramen ovale.
The pulmonary capillaries are a through-passage draining by the pulmonary veins into the left atrium, with no valve in between, so capillary hydrostatic pressure is set downstream by left atrial pressure (normal mean about 4 to 12 mmHg, approximated clinically by the pulmonary capillary wedge pressure, with 15 mmHg or less taken as normal at catheter). Low capillary pressure across a blood-gas barrier well under a micron thick, plus plasma oncotic pressure of about 25 mmHg and continuous lymphatic drainage, is what keeps the air spaces dry.
anything that raises left atrial pressure is felt by the lungs first: interstitial oedema begins once mean left atrial pressure rises above roughly 18 to 20 mmHg acutely and alveolar flooding follows as it approaches plasma oncotic pressure. When the rise is chronic the lymphatics enlarge and higher pressures are carried with surprisingly few crackles.
What goes wrong
- Pulmonary embolism (PE)← from “The bed sits in series with essentially the wh…”
A thrombus from a deep leg or pelvic vein travels through the right heart and wedges in a pulmonary artery - the filter function working against the patient. That lung segment is still ventilated but no longer perfused, so it becomes dead space, ventilation is wasted and the person breathes fast; hypoxaemia comes less from the dead space itself than from redistributed flow, shunt through atelectatic lung and a low mixed venous oxygen when output falls. Because the bed is compliant and recruitable, small emboli barely move the pressure. A large or saddle embolus, with reflex and humoral vasoconstriction on top, raises afterload past what an unprepared right ventricle can generate; it dilates, the septum bows into the left ventricle, filling of the left side falls, and cardiac output collapses.
The lung's filter role is the whole story. Clear chest, clear film, hypoxic and tachypnoeic - think vascular. Massive PE is defined by haemodynamics (sustained hypotension), not by clot size on the scan. In pregnancy or renal impairment a V/Q or perfusion scan is often preferred to CTPA.
You would find: Sudden breathlessness and pleuritic chest pain with a clear chest on auscultation and a chest x-ray that is normal or near-normal. Sinus tachycardia is the commonest ECG finding (S1Q3T3 and right heart strain occur but are uncommon); oxygen saturation is often low, though a normal saturation does not exclude PE; CO2 is low from over-breathing. Hypoxia with a clean-sounding chest is the tell. Stratify with a validated rule such as Wells or the revised Geneva score, then D-dimer if the patient is not high-risk (an age-adjusted cut-off, age times 10 micrograms/L in those over 50, reduces false positives) or straight to CTPA if they are. A swollen calf points to the source; hypotension means the right ventricle is failing.
- Cor pulmonale from chronic hypoxic lung disease← from “Pulmonary arterioles do the opposite of system…”
Hypoxic vasoconstriction is designed to be local. When the whole lung is hypoxic - COPD, obstructive sleep apnoea, obesity hypoventilation, bronchiectasis and chronic suppurative lung disease, which carry a heavy burden in Aboriginal and Torres Strait Islander communities - the entire bed constricts together. Sustained hypoxia also drives remodelling: the arteriolar media thickens, muscle extends into vessels that were previously non-muscular, compliance is lost, and pulmonary artery pressure stays high even when the hypoxia is corrected. The right ventricle hypertrophies, then dilates and fails.
Right heart failure caused by lung disease, not by the left heart - so exclude left-sided disease before accepting the label. The vasoconstrictor component reverses with oxygen; the remodelled component does not, which is why late disease responds less. Correcting hypoxia, not vasodilating, is the treatment.
You would find: Someone with long-standing lung disease who now has a raised JVP (more than about 3 to 4 cm vertically above the sternal angle), ankle oedema and a tender, pulsatile enlarged liver. Loud pulmonary component of the second heart sound and a parasternal heave at the left sternal edge. Resting oxygen saturation is low, and both the saturation and the pulmonary pressure improve with supplemental oxygen - which is the diagnostic and therapeutic point.
- Pulmonary arterial hypertension (group 1)← from “The bed is enormously compliant and much of it…”
The small pulmonary arteries proliferate, thicken and narrow in their own right, so the bed loses the compliance and recruitment it depends on. Haemodynamically this is pre-capillary disease: mean pulmonary artery pressure above 20 mmHg at rest with a pulmonary artery wedge pressure of 15 mmHg or less and pulmonary vascular resistance above 2 Wood units. Because resistance can no longer fall with flow, cardiac output is effectively fixed - breathlessness on exertion, and syncope at peak effort when systemic vasodilatation is not matched by any rise in output. The pressure-loaded right ventricle hypertrophies, then fails.
Diagnosis is haemodynamic, not echocardiographic - echo screens, catheter confirms. Wedge pressure is what separates group 1 (pre-capillary, wedge 15 or less) from group 2 left heart disease (post-capillary, wedge above 15), and that distinction decides whether pulmonary vasodilators help or harm. Group 1 is the rare group; do not treat the common ones as if they were it.
You would find: Progressive exertional breathlessness with a clear chest and near-normal spirometry - the mismatch between how breathless the patient is and how normal the lungs look. Loud P2, a prominent a wave in the JVP while the right ventricle is hypertrophied and sinus rhythm is preserved, and a large v wave with a pansystolic tricuspid regurgitation murmur once the ventricle dilates. Exertional syncope is an ominous sign. Echocardiography estimates right ventricular systolic pressure and screens; right heart catheterisation is required to confirm the diagnosis and to separate pre-capillary from post-capillary disease.
- Pulmonary congestion, pulmonary oedema and post-capillary pulmonary hypertension from left heart disease← from “The pulmonary capillaries are a through-passag…”
The pulmonary capillaries drain into the left atrium with nothing in between, so left-sided pressure is transmitted straight back into them. A stiff or failing left ventricle, or a narrowed mitral valve, raises left atrial pressure; capillary hydrostatic pressure rises past the point where the alveoli can stay dry and fluid moves first into the interstitium and then into the air spaces. Sustained for months, the pulmonary arterioles remodel and add a fixed pre-capillary resistance on top of the passive back-pressure. Left heart disease is the commonest cause of pulmonary hypertension in Australia and worldwide.
Post-capillary: mean pulmonary artery pressure above 20 mmHg with a wedge pressure above 15 mmHg. The treatment is the left-sided lesion and the filling pressure, not the pulmonary vasculature - group 1 vasodilators used here worsen pulmonary oedema.
You would find: Breathless lying flat, waking at night gasping, fine crackles at both bases, frothy or pink sputum, with Kerley B lines, upper-lobe blood diversion and perihilar shadowing on chest x-ray. In rheumatic mitral stenosis - still seen in young Aboriginal and Torres Strait Islander patients - a loud first heart sound, an opening snap, a rumbling mid-diastolic murmur at the apex, exertional breathlessness and haemoptysis.
What we give, and how it works
Open a drug to see what it binds, what that does to the cell, and what you then see in the patient.
- Binds
- Apixaban and rivaroxaban bind the active site of factor Xa, both free and prothrombinase-bound. Enoxaparin binds antithrombin and accelerates it, its shorter chains favouring inhibition of Xa over thrombin. Warfarin inhibits VKORC1.
- Which does
- Blocking Xa stops prothrombin being converted to thrombin, so the burst that converts fibrinogen to fibrin never occurs; warfarin instead depletes the pool of functional vitamin K-dependent factors over days as existing ones are cleared.
- So you see
- Clot propagation stops and recurrent embolism is prevented; the existing embolus is cleared by the patient's own fibrinolysis over weeks, with pressures and symptoms improving as it goes.
- And the same mechanism causes
- Bleeding, as the direct extension of the intended effect - a suppressed cascade cannot seal an injury anywhere. Warfarin adds a mechanism-specific early hazard: protein C has a shorter half-life than factors II, IX and X, so the first day or two of warfarin alone is relatively prothrombotic (the basis of warfarin skin necrosis and of overlapping heparin). Enoxaparin, cleared renally, accumulates as renal function falls and bleeds at an unchanged dose.
- Handling
- Warfarin needs INR monitoring, target 2.0 to 3.0 for venous thromboembolism, and because circulating factors must first be cleared its full antithrombotic effect lags the INR - the INR rises early on the short half-life of factor VII, so parenteral cover is overlapped until it is therapeutic on consecutive days. DOACs have no routine monitoring, but onset and offset are within hours, so a missed dose leaves the patient unprotected with no test to reveal it.
Catches people out: They prevent, they do not dissolve - the clot takes weeks to months to resolve, so an immediate improvement should not be expected. A DOAC is first line in Australia for most PE, but not in every patient: in pregnancy enoxaparin is used, since warfarin is teratogenic and DOACs cross the placenta and are not recommended; in antiphospholipid syndrome (particularly triple-positive) warfarin is preferred to a DOAC; in severe renal impairment enoxaparin accumulates and DOAC use is restricted, so unfractionated heparin or warfarin is used instead.
- Binds
- Plasminogen bound to fibrin within the thrombus; alteplase's activity is greatly enhanced by fibrin binding.
- Which does
- Plasminogen is cleaved to plasmin, which hydrolyses fibrin into degradation products, dissolving the clot lattice.
- So you see
- Rapid fall in pulmonary vascular obstruction and right ventricular afterload within hours, with recovery of cardiac output and blood pressure.
- And the same mechanism causes
- Fibrin selectivity is only relative: plasmin also lyses haemostatic plugs elsewhere and depletes circulating fibrinogen, so major bleeding follows directly from the mechanism. In the randomised data for full-dose systemic thrombolysis in PE, intracranial haemorrhage occurs in roughly 2% and major extracranial bleeding in around 6%, against well under 1% and about 1% with anticoagulation alone.
Catches people out: Reserved for the haemodynamically unstable patient; an ordinary normotensive PE is managed with anticoagulation alone, because in intermediate-risk PE thrombolysis reduces decompensation but the bleeding cost outweighs the benefit. Contraindicated where bleeding would be catastrophic - recent intracranial haemorrhage, known structural intracranial lesion, recent significant head trauma or neurosurgery, active internal bleeding.
- Binds
- No receptor - the oxygen-sensing machinery of pulmonary arterial smooth muscle, where hypoxia inhibits voltage-gated potassium channels.
- Which does
- With alveolar PO2 restored, those potassium channels reopen, the cell repolarises, voltage-gated calcium entry falls and the arteriole relaxes.
- So you see
- Pulmonary vascular resistance and pulmonary artery pressure fall, right ventricular afterload eases, and over months of continuous use survival and polycythaemia improve.
- And the same mechanism causes
- The same abolition of hypoxic pulmonary vasoconstriction is the main reason high-flow oxygen worsens hypercapnia in advanced COPD: perfusion returns to poorly ventilated units, dead space rises, and CO2 climbs - compounded by the Haldane effect as oxygenated haemoglobin releases CO2. Reduced respiratory drive is the smaller contributor, not the main one.
- Handling
- The survival benefit depends on hours of wear, so a concentrator worn overnight and most of the day is not interchangeable with intermittent use for breathlessness; oxygen given for breathlessness in a non-hypoxaemic patient has not been shown to help.
Catches people out: Long-term home oxygen, worn at least 15 hours a day, is prescribed in Australia for a stable resting PaO2 of 55 mmHg or less, or 56 to 59 mmHg with cor pulmonale, pulmonary hypertension or polycythaemia, and is one of the few interventions shown to improve survival in hypoxaemic COPD - smoking cessation is the other, so it is not the only one. In a patient at risk of CO2 retention the accepted target saturation is 88 to 92%, not 100%.
- Binds
- PDE-5 (sildenafil, tadalafil), soluble guanylate cyclase (riociguat), endothelin ET-A/ET-B receptors (macitentan, ambrisentan, bosentan), and the prostacyclin IP receptor (iloprost, epoprostenol) - all on pulmonary arterial smooth muscle and endothelium.
- Which does
- cGMP or cAMP accumulates in the smooth muscle cell, activating protein kinase G or A, lowering intracellular calcium and reducing myosin light chain phosphorylation; endothelin blockade removes a potent constrictor and mitogen. Vasodilatation plus an anti-proliferative effect on the remodelled vessel.
- So you see
- Pulmonary vascular resistance falls, exercise capacity and time to clinical worsening improve, and right ventricular afterload eases.
- And the same mechanism causes
- Vasodilatation is not confined to the lung: systemic hypotension, headache, flushing and nasal congestion follow directly. More specific to this circulation, the drugs dilate vessels supplying poorly ventilated alveoli as readily as well-ventilated ones, abolishing hypoxic pulmonary vasoconstriction and worsening ventilation-perfusion matching, so arterial oxygen can fall as pulmonary pressure improves. Endothelin receptor antagonists cause fluid retention and peripheral oedema through the same receptor blockade in the kidney.
- Handling
- Epoprostenol has a half-life of only a few minutes and is given by continuous central intravenous infusion, so an interrupted line is a life-threatening rebound emergency; iloprost is inhaled several times daily. This drives the choice of agent as much as efficacy does.
Catches people out: These are for group 1 disease. Used in pulmonary hypertension caused by left heart disease they increase flow into a left ventricle that cannot accept it and precipitate pulmonary oedema. A PDE-5 inhibitor with any nitrate causes profound hypotension - nitrates are avoided within 24 hours of sildenafil and 48 hours of tadalafil - and riociguat must not be combined with a PDE-5 inhibitor at all. Endothelin receptor antagonists are teratogenic and require pregnancy prevention and monitoring; bosentan additionally requires monthly liver function tests and induces CYP3A4, reducing hormonal contraceptive levels.
- Binds
- NKCC2 in the apical membrane of thick ascending limb cells, reached from the tubular lumen after secretion by proximal organic anion transporters.
- Which does
- Sodium, potassium and chloride reabsorption is blocked; this also dissipates the lumen-positive potential that drives paracellular calcium and magnesium reabsorption and abolishes the medullary concentrating gradient.
- So you see
- Brisk diuresis with a fall in intravascular volume and filling pressures; breathlessness, crackles, JVP and oedema settle, often before much weight has been lost - venodilatation contributes to the earliest relief.
- And the same mechanism causes
- The transporter block itself produces hypokalaemia, hypomagnesaemia, hypocalcaemia and a hypochloraemic metabolic alkalosis, with hypovolaemia and prerenal impairment if pushed; the closely related NKCC1 in the stria vascularis of the inner ear accounts for ototoxicity with large or rapidly infused intravenous doses. In this setting the specific danger is preload dependence - the same volume removal that dries the lungs can empty a right ventricle that needs filling pressure to eject.
Catches people out: It relieves congestion but does nothing to the underlying valve, ventricle or pulmonary vasculature. A pressure-loaded or dilated right ventricle sits on the steep part of its filling curve and depends on preload: over-diurese in pulmonary hypertension or right ventricular infarction and stroke volume, cardiac output and blood pressure fall.
Pulmonary arterioles behave backwards compared with systemic ones: low ALVEOLAR oxygen constricts them. Patchy, that is useful - blood is diverted to lung that is working. Across both lungs it lifts pulmonary artery pressure until the thin right ventricle gives way, which is why oxygen, not a vasodilator, is the treatment for cor pulmonale, and why group 1 vasodilators can drop the arterial oxygen by abolishing the same reflex. The single number that decides management is the wedge pressure: above 15 mmHg the problem is the left heart and vasodilators harm; 15 or less with a pulmonary vascular resistance above 2 Wood units is group 1 and they help. And a breathless, hypoxic patient with a clear chest and a normal chest x-ray has a vascular problem until proven otherwise - think pulmonary embolism.
Now test whether it stuck
Reading this through is not the same as being able to reconstruct it. Every question in the bank is free, with a full debrief on each option.